Insider Transactions

What Braveheart Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	13	13
Sells	0	0
Total trades	19	19

Shares traded

	3 months	12 months
Acquired	60,775,913	60,775,913
Disposed	0	0
Net activity	+60,775,913	+60,775,913

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Forbion Growth Opportunities Fund Iii Cooperatief U.a.	10% owner	Aug 07	Open-market buy · P	+1,680,000	$18.00	+$30.2M	10,185,478
Forbion Growth Opportunities Fund Iii Cooperatief U.a.	10% owner	Aug 07	Open-market buy · P	+1,920,000	$18.00	+$34.6M	11,640,546
Forbion Growth Opportunities Fund Iii Cooperatief U.a.	10% owner	Aug 07	Derivative Conversion · C	+7,990,867	—	—	8,505,478
Forbion Growth Opportunities Fund Iii Cooperatief U.a.	10% owner	Aug 07	Derivative Conversion · C	+9,132,420	—	—	9,720,546
Murdoch Travis	CEO and President	Aug 07	Open-market buy · P	+83,333	$18.00	+$1.5M	2,940,670
Lubner David Charles	Director	Aug 07	Open-market buy · P	+55,555	$18.00	+$1M	55,555
Malek David I	Director	Aug 07	Open-market buy · P	+4,166	$18.00	+$75K	533,845
Anderson Michele A.	Chief Development Officer	Aug 07	Open-market buy · P	+1,111	$18.00	+$20K	332,161
Rickey James Paul	Chief Financial Officer	Aug 07	Open-market buy · P	+27,777	$18.00	+$500K	520,927
Viehbacher Christopher	Director	Aug 07	Open-market buy · P	+83,333	$18.00	+$1.5M	609,519
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	10% owner	Aug 07	Derivative Conversion · C	+7,420,091	—	—	7,420,091
Chimovits Erez	Director	Aug 07	Open-market buy · P	+273,333	$18.00	+$4.92M	273,333
Chimovits Erez	Director	Aug 07	Open-market buy · P	+1,666,667	$18.00	+$30M	11,901,826
Chimovits Erez	Director	Aug 07	Derivative Conversion · C	+9,132,420	—	—	10,235,159
Orbimed Advisors Llc	Director	Aug 07	Open-market buy · P	+273,333	$18.00	+$4.92M	273,333
Orbimed Advisors Llc	Director	Aug 07	Open-market buy · P	+1,666,667	$18.00	+$30M	11,901,826
Orbimed Advisors Llc	Director	Aug 07	Derivative Conversion · C	+9,132,420	—	—	10,235,159
Ah Bio Fund IV, L.p.	10% owner	Aug 07	Open-market buy · P	+1,100,000	$18.00	+$19.8M	10,232,420
Ah Bio Fund IV, L.p.	10% owner	Aug 07	Derivative Conversion · C	+9,132,420	—	—	9,132,420

Page 1 of 1 · showing the 19 most recent Sign up free to view all 19 transactions and filter by insider →

Comments